A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

Michael Malinchoc, Patrick S. Kamath, Fredric D. Gordon, Craig J. Peine, Jeffrey Rank, Pieter C.J. ter Borg – 30 December 2003 – Transjugular intrahepatic portosystemic shunts (TIPS) may worsen liver function and decrease survival in some patients. The Child‐Pugh classification has several drawbacks when used to determine survival in such patients.

Tumor necrosis factor α down‐regulates expression of the α1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ‐ and C/EBPδ‐dependent mechanism

María J. Iraburu, José A. Domínguez‐Rosales, Luis Fontana, Anitra Auster, Elena R. García‐Trevijano, Amador Covarrubias‐Pinedo, Ana María Rivas‐Estilla, Patricia Greenwel, Marcos Rojkind – 30 December 2003 – Tumor necrosis factor α (TNF‐α) is one of the key cytokines of the acute phase response and of many inflammatory processes. This cytokine has several antifibrogenic actions and down‐regulates the expression of the type I collagen genes and induces the expression of metalloproteinases.

Host genetic factors influence disease progression in chronic hepatitis C

Elizabeth E. Powell, Catherine J. Edwards‐Smith, John L. Hay, Andrew D. Clouston, Darrell H. Crawford, Claudia Shorthouse, David M. Purdie, Julie R. Jonsson – 30 December 2003 – Progressive hepatic fibrosis and cirrhosis develops in 20% to 30% of patients with chronic hepatitis C virus (HCV). We propose that host genetic factors influencing fibrogenesis may account for some of the variability in progression of this disease.

production and release of endothelin‐1 from the gut and spleen in portal hypertension due to cirrhosis

Naofumi Nagasue, Dipok Kumar Dhar, Akira Yamanoi, Yamaguchi Emi, Jun Udagawa, Akitaka Yamamoto, Mitsuo Tachibana, Hirofumi Kubota, Hitoshi Kohno, Takayuki Harada – 30 December 2003 – This study was aimed to evaluate the source of endothelin‐1 (ET‐1) in cirrhotic patients. ET‐1 is implicated in the pathogenesis of portal hypertension. However, the mechanism and source for increased plasma ET‐1 in cirrhotic patients are still obscure.

Induction by interleukin 6 of Gs‐coupled prostaglandin E2 receptors in rat hepatocytes mediating a prostaglandin E2–dependent inhibition of the hepatocyte's acute phase response

Alexandra Fennekohl, Maria Lucas, Gerhard P. Püschel – 30 December 2003 – Prostanoids, that are released from nonparenchymal liver cells in response to proinflammatory stimuli, are involved in the regulation of hepatic functions during inflammation. They exert their effects on their target cells via heptahelical receptors in the plasma membrane. For the 5 prostanoids prostaglandin E2 (PGE2), prostaglandin F2α, prostaglandin D2(PGD2), prostacyclin, and thromboxane A2 there exist 8 receptors that are coupled to different heterotrimeric G proteins.

Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy

Bertrand Condat, Fabienne Pessione, Marie Helene Denninger, Sophie Hillaire, Dominique Valla – 30 December 2003 – Characteristics and outcomes of recent portal or mesenteric venous thrombosis are ill‐known. We intended to compare these features with those of patients with portal cavernoma, and also to assess the incidence of recanalization of recent thrombosis on anticoagulation therapy.

Hyperstimulation With Interleukin 6 Inhibits Cell Cycle Progression After Hepatectomy in Mice

Torsten Wüstefeld, Tim Rakemann, Stefan Kubicka, Michael P. Manns, Christian Trautwein – 30 December 2003 – Interleukin 6 (IL‐6) is an important mediator of hepatocyte proliferation after hepatectomy. However, elevated IL‐6 levels are found in patients with chronic liver disease. Therefore, it is unclear if hyperstimulation with IL‐6 may have an influence on liver regeneration. We investigated whether a strong activation of IL‐6–dependent pathways may change the course of hepatocyte proliferation after hepatectomy.

Subscribe to